H.A.C. Pharma is a French independent pharmaceutical “Exploitant” company.

Since 2007, H.A.C. Pharma is delivering mature and innovative high value drugs to patients through distribution, in-licensing and acquisition deals.

H.A.C. Pharma has unique end-to-end capabilities to market high therapeutic value drugs on the French market, especially in pathologies with reduced alternatives for the patient.

H.A.C. Pharma is a partner of choice to integrate your products at any step of their lifecycle: from regulatory and market access strategy, to product importation and distribution, including marketing and sales strategy, when required.

The company's drugs are promoted in France, with its own sales force, to specialists in hospital and retail channels in the area of endocrinology, neurology, gynecology, onco-hematology and gastroenterology.

H.A.C. Pharma also works with a network of trusted distributors in 6 European countries (Spain, Italy, Belgium, Austria, Switzerland and Portugal).

HAC Pharma

Philippe BISSAY

This department focuses on monitoring the safety and efficacy of pharmaceutical products through data collection and analysis.

Pharmacovigilance Services

This department oversees financial planning, analysis, and reporting to ensure organizational fiscal health.

Financial Management

This department is responsible for the strategic and scientific communication of medical information and support for product development and lifecycle.

Medical Affairs

This department ensures the quality and compliance of suppliers and service providers.

Quality Assurance

This department manages technical regulations and compliance across various regions.

HAC Pharma

Org chart

Teams

Pharmacovigilance Services

Financial Management

Medical Affairs

Quality Assurance

Regulatory Affairs

Offices

HAC Pharma

Org chart

Teams

Pharmacovigilance Services

Financial Management

Medical Affairs

Quality Assurance

Regulatory Affairs

Offices

Related companies